Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials.
By N. Boissel, M. Auclerc, V. Lheritier, Y. Pérel, X. Thomas, T. Leblanc, P. Rousselot, J. Cayuela, J. Gabert, N. Fegueux and 10 more. Journal of Clinical Oncology, 2003
623 citations recorded by the source corpus.
Subfields: Pathology and Forensic Medicine, Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/ce455c728629d45752f6c2e7cc2b23ee3fd707d9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pathology and Forensic Medicine
In Pediatrics, Perinatology and Child Health
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Long‐term follow‐up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper‐CVAD), a dose‐intensive regimen, in adult acute lymphocytic leukemia (2004, neutral): “Age (yrs) 40 147 (51) 40–59 82 (28) 60 59 (20) Performance score (ECOG scale) 3–4 19 (7) Splenomegaly Yes 76 (26) Hepatomegaly Yes 44 (15) Lymphadenopathy Yes 91 (32) CNS disease at diagnosis Yes 19 (7) Mediastinal mass Yes 20 (7) Leukocyte count ( 10(9)/L) 5 105 (36) 5–49 135 (47) 50 48 (17) Platel”
- Cancer treatment and survivorship statistics, 2012 (2012, background): “Studies have shown that for young adult patients diagnosed with acute lymphocytic leukemia (ALL), outcomes are improved on pediatric, as opposed to adult, protocols.(27,28) For AYAs diagnosed with cancers more common among adults, such as breast and colorectal cancers, treatment by adult-care specia”
- Cancer treatment and survivorship statistics, 2014 (2014, background): “pediatric protocols result in better outcomes than adult protocols.(41,42) For adolescent patients diagnosed with cancers”